Novel perspectives on therapeutic modulation of the gut microbiota

Therapeutic Advances in Gastroenterology

Volumn 9, Issue 4, 2016, Pages 580-593

  McCarville, Justin L ^a   Caminero, Alberto ^a   Verdu, Elena F ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

fecal microbiota transplant; inflammatory bowel disease; irritable bowel syndrome; microbiota; prebiotics; probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIOPHAGE; CARCINOGENESIS; CELLULAR IMMUNITY; DENDRITIC CELL; DIET THERAPY; DISEASE CONTROL; ENTEROPATHY; ENVIRONMENTAL FACTOR; FECAL MICROBIOTA TRANSPLANTATION; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA; METABOLIC DISORDER; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW;

EID: 84975068615     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X16637819     Document Type: Review

References (138)

1. Abraham C., Cho J., (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
2. Alang N., Kelly C., (2015) Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2: ofv004.
3. Arpaia N., Campbell C., Fan X., Dikiy S., Van Der Veeken J., Deroos P., et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455.
4. Atarashi K., Tanoue T., Ando M., Kamada N., Nagano Y., Narushima S., et al. (2015) Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163: 367-380.
5. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
6. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
7. Backhed F., Ding H., Wang T., Hooper L., Koh G., Nagy A., et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15723.
8. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., et al. (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599-609.e3.
9. Berni Canani R., Sangwan N., Stefka A.T., Nocerino R., Paparo L., Aitoro R., et al. (2016) Lactobacillus rhamnosus Gg-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J 10: 742-750.
10. Bindels L., Delzenne N., Cani P., Walter J., (2015) Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 12: 303-310.
11. Bindels L., Walter J., Ramer-Tait A., (2015) Resistant starches for the management of metabolic diseases. Curr Opin Clin Nutr Metab Care 18: 559-565.
12. Bohn L., Storsrud S., Liljebo T., Collin L., Lindfors P., Tornblom H., et al. (2015) Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 149: 1399-1407.e2.
13. Bordin M., D'Atri F., Guillemot L., Citi S., (2004) Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2: 692-701.
14. Braga T., Da Silva G., De Lira P., De Carvalho Lima M., (2011) Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 93: 81-86.
15. Brestoff J., Artis D., (2013) Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14: 676-684.
16. Brown E., Wlodarska M., Willing B., Vonaesch P., Han J., Reynolds L., et al. (2015) Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun 6: 7806.
17. Buffie C., Bucci V., Stein R., McKenney P., Ling L., Gobourne A., et al. (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517: 205-208.
18. Buffie C., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., et al. (2012) Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80: 62-73.
19. Bures J., Cyrany J., Kohoutova D., Forstl M., Rejchrt S., Kvetina J., et al. (2010) Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 16: 2978-2990.
20. Cani P., Everard A., (2016) Talking microbes: when gut bacteria interact with diet and host organs. Mol Nutr Food Res 60: 58-66.
21. Carding S., Verbeke K., Vipond D., Corfe B., Owen L., (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26: 26191.
22. Carlsson A., Yakymenko O., Olivier I., Hakansson F., Postma E., Keita A., et al. (2013) Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 48: 1136-1144.
23. Collins J., Auchtung J., Schaefer L., Eaton K., Britton R., (2015) Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome 3: 35.
24. Collins S., (2014) A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 11: 497-505.
25. Costeloe K., Hardy P., Juszczak E., Wilks M., Millar M., (2016) Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387: 649-660.
26. Cotillard A., Kennedy S., Kong L., Prifti E., Pons N., Le Chatelier E., et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature 500: 585-588.
27. Cox A., West N., Cripps A., (2015) Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol 3: 207-215.
28. Dalal S., Chang E., (2014) The microbial basis of inflammatory bowel diseases. J Clin Invest 124: 4190-4196.
29. Daniel H., Moghaddas Gholami A., Berry D., Desmarchelier C., Hahne H., Loh G., et al. (2014) High-fat diet alters gut microbiota physiology in mice. ISME J 8: 295-308.
30. David L., Maurice C., Carmody R., Gootenberg D., Button J., Wolfe B., et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
31. De Filippis F., Pellegrini N., Vannini L., Jeffery I., La Storia A., Laghi L., et al. (2015) High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 28 (Epub ahead of print).
32. De Palma G., Blennerhassett P., Lu J., Deng Y., Park A., Green W., et al. (2015) Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun 6: 7735.
33. De Palma G., Collins S., Bercik P., (2014) The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 5: 419-429.
34. De Palma G., Nadal I., Medina M., Donat E., Ribes-Koninckx C., Calabuig M., et al. (2010) Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 10: 63.
35. Deshpande A., Pasupuleti V., Thota P., Pant C., Rolston D., Sferra T., et al. (2013) Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 68: 1951-1961.
36. Devkota S., Wang Y., Musch M., Leone V., Fehlner-Peach H., Nadimpalli A., et al. (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/- mice. Nature 487: 104-108.
37. Dewulf E., Cani P., Claus S., Fuentes S., Puylaert P., Neyrinck A., et al. (2013) Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62: 1112-1121.
38. Dey N., Wagner V., Blanton L., Cheng J., Fontana L., Haque R., et al. (2015) Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell 163: 95-107.
39. Dore J., Blottiere H., (2015) The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol 32: 195-199.
40. Drossman D., Chang L., Bellamy N., Gallo-Torres H., Lembo A., Mearin F., et al. (2011) Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol 106: 1749-1759; quiz 1760.
41. Duerkop B., Clements C., Rollins D., Rodrigues J., Hooper L., (2012) A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A 109: 17621-17626.
42. El Aidy S., Van Baarlen P., Derrien M., Lindenbergh-Kortleve D., Hooiveld G., Levenez F., et al. (2012) Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol 5: 567-579.
43. Everard A., Belzer C., Geurts L., Ouwerkerk J., Druart C., Bindels L., et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110: 9066-9071.
44. Furusawa Y., Obata Y., Fukuda S., Endo T., Nakato G., Takahashi D., et al. (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450.
45. Galipeau H., McCarville J., Huebener S., Litwin O., Meisel M., Jabri B., et al. (2015) Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol 185: 2969-2982.
46. Gibson G., Roberfroid M., (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125: 1401-1412.
47. Gkouskou K., Deligianni C., Tsatsanis C., Eliopoulos A., (2014) The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 4: 28.
48. Gough E., Shaikh H., Manges A., (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53: 994-1002.
49. Gupta P., Andrew H., Kirschner B., Guandalini S., (2000) Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31: 453-457.
50. Guslandi M., Mezzi G., Sorghi M., Testoni P., (2000) Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45: 1462-1464.
51. Halland M., Saito Y., (2015) Irritable bowel syndrome: new and emerging treatments. BMJ 350: h1622.
52. Halmos E., Christophersen C., Bird A., Shepherd S., Gibson P., Muir J., (2015) Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 64: 93-100.
53. Halmos E., Power V., Shepherd S., Gibson P., Muir J., (2014) A diet low in fodmaps reduces symptoms of irritable bowel syndrome. Gastroenterology 146: 67-75.e65.
54. Hamilton M., Boudry G., Lemay D., Raybould H., (2015) Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol 308: G840-G851.
55. Hansen J., Gulati A., Sartor R., (2010) The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol 26: 564-571.
56. Hill D., Hoffmann C., Abt M., Du Y., Kobuley D., Kirn T., et al. (2010) Metagenomic analyses lreveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3: 148-158.
57. Horai R., Zarate-Blades C., Dillenburg-Pilla P., Chen J., Kielczewski J., Silver P., et al. (2015) Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity 43: 343-353.
58. Hughes R., Cross A., Pollock J., Bingham S., (2001) Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 22: 199-202.
59. Ivanov I., Atarashi K., Manel N., Brodie E., Shima T., Karaoz U., et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
60. Jin U., Lee S., Sridharan G., Lee K., Davidson L., Jayaraman A., et al. (2014) Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 85: 777-788.
61. Kanther M., Tomkovich S., Xiaolun S., Grosser M., Koo J., Flynn E. 3rd, et al. (2014) Commensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A. Cell Microbiol 16: 1053-1067.
62. Kaser A., Zeissig S., Blumberg R., (2010) Inflammatory bowel disease. Annu Rev Immunol 28: 573-621.
63. Kau A., Ahern P., Griffin N., Goodman A., Gordon J., (2011) Human nutrition, the gut microbiome and the immune system. Nature 474: 327-336.
64. Kelly C., Zheng L., Campbell E., Saeedi B., Scholz C., Bayless A., et al. (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17: 662-671.
65. Koeth R., Wang Z., Levison B., Buffa J., Org E., Sheehy B., et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19: 576-585.
66. Kverka M., Zakostelska Z., Klimesova K., Sokol D., Hudcovic T., Hrncir T., et al. (2011) Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through Modulation of Immunity and Microbiota Composition. Clin Exp Immunol 163: 250-259.
67. Lawley T., Clare S., Walker A., Stares M., Connor T., Raisen C., et al. (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8: e1002995.
68. Le Barz M., Anhe F., Varin T., Desjardins Y., Levy E., Roy D., et al. (2015) Probiotics as complementary treatment for metabolic disorders. Diabetes Metab J 39: 291-303.
69. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
70. Lee D., Albenberg L., Compher C., Baldassano R., Piccoli D., Lewis J., et al. (2015) Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 148: 1087-1106.
71. Lepage P., Colombet J., Marteau P., Sime-Ngando T., Dore J., Leclerc M., (2008) Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 57: 424-425.
72. Leung J., Loke P., (2013) A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity. Int J Parasitol 43: 253-257.
73. Levy M., Thaiss C., Zeevi D., Dohnalova L., Zilberman-Schapira G., Mahdi J., et al. (2015) Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163: 1428-1443.
74. Lewis K., Lutgendorff F., Phan V., Soderholm J., Sherman P., McKay D., (2010) Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16: 1138-1148.
75. Logan A., Chow K., George A., Weinstein P., Cebra J., (1991) Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii. Infect Immun 59: 1024-1031.
76. Longstreth G., Thompson W., Chey W., Houghton L., Mearin F., Spiller R., (2006) Functional bowel disorders. Gastroenterology 130: 1480-1491.
77. Macia L., Tan J., Vieira A., Leach K., Stanley D., Luong S., et al. (2015) Metabolite-sensing receptors GPR43 and GPR109a facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6: 6734.
78. Macpherson A., Harris N., (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4: 478-485.
79. Madsen K., (2001) Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin Invest Med 24: 250-257.
80. Malchow H., (1997) Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 25: 653-658.
81. Mao Y., Nobaek S., Kasravi B., Adawi D., Stenram U., Molin G., et al. (1996) The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111: 334-344.
82. Marafini I., Monteleone I., Di Fusco D., Cupi M., Paoluzi O., Colantoni A., et al. (2015) TNF-alpha producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice. PLoS One 10: e0126291.
83. Mayne C., Williams C., (2013) Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis 19: 1772-1788.
84. McKenzie A., Spits H., Eberl G., (2014) Innate lymphoid cells in inflammation and immunity. Immunity 41: 366-374.
85. Mills S., Shanahan F., Stanton C., Hill C., Coffey A., Ross R., (2013) Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4: 4-16.
86. Moayyedi P., Ford A., Talley N., Cremonini F., Foxx-Orenstein A., Brandt L., et al. (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59: 325-332.
87. Moayyedi P., Surette M., Kim P., Libertucci J., Wolfe M., Onischi C., et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149: 102-109.e6.
88. Natividad J., Pinto-Sanchez M., Galipeau H., Jury J., Jordana M., Reinisch W., et al. (2015) Ecobiotherapy rich in Firmicutes decreases susceptibility to colitis in a humanized gnotobiotic mouse model. Inflamm Bowel Dis 21: 1883-1893.
89. Natividad J., Verdu E., (2013) Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 69: 42-51.
90. Norman J., Handley S., Baldridge M., Droit L., Liu C., Keller B., et al. (2015) Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160: 447-460.
91. Ochoa-Reparaz J., Mielcarz D., Ditrio L., Burroughs A., Foureau D., Haque-Begum S., et al. (2009) Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 183: 6041-6050.
92. O'Mahony L., Feeney M., O'Halloran S., Murphy L., Kiely B., Fitzgibbon J., et al. (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15: 1219-1225.
93. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.
94. Pabst O., Mowat A., (2012) Oral tolerance to food protein. Mucosal Immunol 5: 232-239.
95. Palomares O., Yaman G., Azkur A., Akkoc T., Akdis M., Akdis C., (2010) Role of Treg in immune regulation of allergic diseases. Eur J Immunol 40: 1232-1240.
96. Paul B., Barnes S., Demark-Wahnefried W., Morrow C., Salvador C., Skibola C., et al. (2015) Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics 7: 112.
97. Peng L., He Z., Chen W., Holzman I., Lin J., (2007) Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61: 37-41.
98. Peng L., Li Z., Green R., Holzman I., Lin J., (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139: 1619-1625.
99. Perez-Brocal V., Garcia-Lopez R., Vazquez-Castellanos J., Nos P., Beltran B., Latorre A., et al. (2013) Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin Transl Gastroenterol 4: e36.
100. Prantera C., Scribano M., Falasco G., Andreoli A., Luzi C., (2002) Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51: 405-409.
101. Qiu J., Guo X., Chen Z., He L., Sonnenberg G., Artis D., et al. (2013) Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39: 386-399.
102. Rijkers G., De Vos W., Brummer R., Morelli L., Corthier G., Marteau P., (2011) Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr 106: 1291-1296.
103. Roberfroid M., Gibson G., Hoyles L., McCartney A., Rastall R., Rowland I., et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104 (Suppl. 2): S1-S63.
104. Rohlke F., Stollman N., (2012) Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 5: 403-420.
105. Rolhion N., Darfeuille-Michaud A., (2007) Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 13: 1277-1283.
106. Round J., Mazmanian S., (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323.
107. Sanchez E., Nadal I., Donat E., Ribes-Koninckx C., Calabuig M., Sanz Y., (2008) Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol 8: 50.
108. Schaubeck M., Clavel T., Calasan J., Lagkouvardos I., Haange S., Jehmlich N., et al. (2015) Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut 65: 225-237.
109. Scher J., Ubeda C., Artacho A., Attur M., Isaac S., Reddy S., et al. (2015) Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 67: 128-139.
110. Schultz M., Veltkamp C., Dieleman L., Grenther W., Wyrick P., Tonkonogy S., et al. (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 8: 71-80.
111. Sefik E., Geva-Zatorsky N., Oh S., Konnikova L., Zemmour D., McGuire A., et al. (2015) Mucosal immunology. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349: 993-997.
112. Seo S., Kamada N., Munoz-Planillo R., Kim Y., Kim D., Koizumi Y., et al. (2015) Distinct commensals induce interleukin-1beta via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 42: 744-755.
113. Shroff K., Cebra J., (1995) Development of mucosal humoral immune responses in germ-free (GF) mice. Adv Exp Med Biol 371A: 441-446.
114. Sivan A., Corrales L., Hubert N., Williams J., Aquino-Michaels K., Earley Z., et al. (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350: 1084-1089.
115. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L., Gratadoux J., et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
116. Sonnenberg G., Artis D., (2015) Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21: 698-708.
117. Sonnenburg E., Smits S., Tikhonov M., Higginbottom S., Wingreen N., Sonnenburg J., (2016) Diet-induced extinctions in the gut microbiota compound over generations. Nature 529: 212-215.
118. Stefka A., Feehley T., Tripathi P., Qiu J., McCoy K., Mazmanian S., et al. (2014) Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 111: 13145-13150.
119. Sun J., Furio L., Mecheri R., Van Der Does A., Lundeberg E., Saveanu L., et al. (2015a) Pancreatic beta-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43: 304-317.
120. Sun M., He C., Cong Y., Liu Z., (2015b) Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol 8: 969-978.
121. Theriot C., Koenigsknecht M., Carlson P. Jr, Hatton G., Nelson A., Li B., et al. (2014) Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5: 3114.
122. Thorburn A., Macia L., Mackay C., (2014) Diet, metabolites, and 'western-lifestyle' inflammatory diseases. Immunity 40: 833-842.
123. Thorburn A., McKenzie C., Shen S., Stanley D., Macia L., Mason L., et al. (2015) Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 6: 7320.
124. Turnbaugh P., Ley R., Mahowald M., Magrini V., Mardis E., Gordon J., (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
125. Vaishnava S., Behrendt C., Ismail A., Eckmann L., Hooper L., (2008) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 105: 20858-20863.
126. Vangay P., Ward T., Gerber J., Knights D., (2015) Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17: 553-564.
127. Venturi A., Gionchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., et al. (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13: 1103-1108.
128. Verdu E., Bercik P., Verma-Gandhu M., Huang X., Blennerhassett P., Jackson W., et al. (2006) Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182-190.
129. Wacklin P., Laurikka P., Lindfors K., Collin P., Salmi T., Lahdeaho M., et al. (2014) Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet. Am J Gastroenterol 108: 1933-1941.
130. Wagner J., Maksimovic J., Farries G., Sim W., Bishop R., Cameron D., et al. (2013) Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm Bowel Dis 19: 1598-1608.
131. Walters W., Xu Z., Knight R., (2014) Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588: 4223-4233.
132. Wang Q., Dong J., Zhu Y., (2012) Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 47: 241-248.
133. Wing K., Sakaguchi S., (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7-13.
134. Wolvers D., Antoine J., Myllyluoma E., Schrezenmeir J., Szajewska H., Rijkers G., (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 140: 698S-712S.
135. Wu G., Chen J., Hoffmann C., Bittinger K., Chen Y., Keilbaugh S., et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108.
136. Zelante T., Iannitti R., Cunha C., De Luca A., Giovannini G., Pieraccini G., et al. (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39: 372-385.
137. Zenewicz L., Yancopoulos G., Valenzuela D., Murphy A., Stevens S., Flavell R., (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
138. Zenewicz L., Yin X., Wang G., Elinav E., Hao L., Zhao L., et al. (2013) IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol 190: 5306-5312.